Delivery Order SPE2D021D0005-SPE2D325F386E
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of oseltamivir phosphate (Tamiflu), an antiviral medication. The $141,052.05 firm-fixed-price delivery order is not associated with any set-aside designation. Genentech holds several established contract vehicles with federal agencies, including a $4.9 billion Federal Supply Schedule with the Department of Veterans Affairs to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Genentech USA, Inc., a biotechnology company that develops and manufactures pharmaceuticals. The contract is for the antiviral medication Oseltamivir Phosphate, also known as Tamiflu, with a potential value of $112,841.64. The contract has a firm fixed price pricing type and a completion date of September 23, 2019. Genentech, as the prime contractor, will perform the work at its facility in...
- Genentech USA, Inc. was awarded a $112 firm fixed price delivery order against an unidentified contract vehicle to supply 4554769784 Tamiflu 75 mg capsules in blister packs of 10 to the Defense Logistics Agency Troop Support Medical. Performance will occur in South San Francisco, California by September 17, 2021. No set-aside provisions were applied to this order for pharmaceutical supplies in support of the agency's medical logistics programs. Genentech will serve as the prime contractor to...
- The Defense Logistics Agency Troop Support Medical awarded a $1,184.20 delivery order contract to Genentech USA, Inc. of South San Francisco, California. The firm fixed price order is for 4556060395 Tamiflu 75 mg capsules blister pack/10 to be delivered from January 26 to January 31, 2022. As the prime contractor, Genentech will supply the requested Tamiflu medication to DLA Troop Support Medical, the logistics agency of the U.S. Department of Defense, in support of its mission to provide...
- The Defense Logistics Agency Troop Support Medical awarded a $4,343,441.64 firm fixed price delivery order to Genentech USA, Inc. for the purchase of the antiviral medication oseltamivir phosphate. This order was placed against an existing indefinite delivery contract with the biotechnology manufacturer, which has a history of providing various pharmaceutical products to federal agencies such as the Departments of Health and Human Services, Defense, Justice, and Veterans Affairs. Genentech...
- This is a $159,762.84 delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc. for the supply of the antiviral medication oseltamivir phosphate. The contract has a firm fixed price and a completion date of September 11, 2018. Genentech USA, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical products, and this order was likely issued against an existing indefinite delivery contract or Federal Supply Schedule to support the...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc., a biotechnology company and manufacturer of pharmaceuticals. The $115,283.85 firm fixed-price contract is for the antiviral medication oseltamivir phosphate, with a completion date of August 2, 2023. Genentech, which has provided various drugs to federal agencies through indefinite delivery contracts and Federal Supply Schedule agreements, will perform the work at its facility in...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology company. The $93,573.18 firm-fixed-price contract is for the delivery of oseltamivir phosphate, an antiviral medication. The award falls under a larger indefinite delivery contract between Genentech and DLA valued at $27.9 million to supply medical supplies and critical pharmaceuticals for the Department of Defense. No set-aside designation was used....
- The Defense Logistics Agency Troop Support Medical awarded a $992,671.83 firm fixed price delivery order to Genentech USA, Inc., a foreign-owned, for-profit manufacturer, for the procurement of the antiviral medication oseltamivir phosphate. This order was placed against an existing contract vehicle and does not utilize a set-aside designation. Genentech, a biotechnology company, has provided various pharmaceutical products to federal agencies such as the Departments of Health and Human...
- This is a delivery order awarded to Genentech USA, Inc., a biotechnology company that develops and manufactures pharmaceuticals, by the Defense Logistics Agency Troop Support Medical. The contract is for the antiviral medication oseltamivir phosphate, with a potential value of $468,558.18 and a firm fixed price pricing type. The place of performance is Genentech's facility in South San Francisco, California. The contract does not utilize any set-asides. Genentech has extensive experience...
- SPE2D021D0005Indefinite Delivery Contract
- SPE2D021D0005-SPE2D325F386EDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to Genentech USA, Inc. for Tamiflu (oseltamivir) 75 mg capsules with a contract ceiling value of $1,387.32. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 9, 2025, represents a small targeted procurement of antiviral medication. The award was made without a set-aside designation, indicating open competition. Genentech USA, Inc., a foreign-owned pharmaceutical manufacturer headquartered in South San Francisco, California, will perform the work at its facility in South San Francisco, CA 94080. This delivery order is executed under one of Genentech's existing indefinite delivery contract vehicles with the Defense Logistics Agency Troop Support Medical ($27.9 million, valid through May 2031), which enables flexible procurement of critical medical supplies and pharmaceuticals. The award reflects the federal government's reliance on Genentech's established supply chain capabilities for emergency preparedness and medical stockpiling purposes. Genentech maintains several significant pharmaceutical supply contracts across multiple federal agencies, including the Department of Veterans Affairs and the Office of the Assistant Secretary for Preparedness and Response, positioning the company as a key supplier of essential medications to the federal healthcare and defense infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/4/25 |